İbrahim Serkan Avşar

İbrahim Serkan Avşar

Auto-generated profile, based on publicly available information

İbrahim Serkan Avşar

TOKAT GAZİOSMANPAŞA ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2023 in Ankara Universitesi Eczacilik Fakultesi Dergisi
Verified
Journal Article
Open access
PDF file
DDDerya Doğanay
Derya Doğanay
MAMüzeyyen Aydin
Müzeyyen Aydin
IAİbrahim Serkan Avşar
İbrahim Serkan Avşar
Amaç: Son yıllarda genişlemiş spektrumlu beta laktamaz (GSBL) üretimi sonucu ortaya çıkan direncin bakteriler arasında hızla yayılabilmesi K. pneumoniae bakterisinin önemini arttırmıştır. Bakterilerin antibiyotik direnç oranlarının düzenli takibi enfeksiyonların tedavisi ve geliştirilebilecek yeni tedavi yöntemleri için oldukça önemlidir. Çalışmada COVID-19 Pandemisini kapsayan Mart 2020 – Mart 2021 tarihleri arasında Biruni Üniversitesi Hastanesi’ne başvuran hastalardan izole edilen K. pneumoniae’ların antibiyotik direnç profilleri ve GSBL pozitiflik oranlarının belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Çalışmada farklı poliklinik ve servislerden gönderilen örneklerden izole edilen K. pneumoniae bakterilerinin antibiyogram test sonuçları ve GSBL varlıkları retrospektif olarak değerlendirilmiştir. İstatistiksel analizler için GraphPad InStat V. 3.05 kullanılmıştır. Sonuç ve Tartışma: Çalışmada farklı klinik örneklerden 423 K. pneumoniae bakterisi izole edilmiştir. İzolatların 161’i (%38) endotrakeal aspirat (ETA) örneğinden, 349’u (%82,5) yoğun bakım kliniğinden elde edilmiştir. Ayrıca izolatların 358’i (%84.63) GSBL pozitif, 65’i (%15.36) GSBL negatif olarak belirlenmiştir. Elde edilen izolatların çoğunluğunun ampisiline karşı, GSBL pozitif olan izolatların tamamına yakınının ise seftazidime karşı dirençli olduğu görülmüştür. Gerek yapılan çalışmalar gerekse çalışmada ortaya çıkan sonuçlar, çoklu antibiyotik direnci gösteren K. pneumoniae suşlarının sayısının zaman içerisinde arttığını ve bu artışın katlanarak devam ettiğini göstermektedir.

31 December 2025 in Journal of Immunology and Clinical Microbiology
Verified
Journal Article
Open access
İAİbrahim Serkan Avşar
İbrahim Serkan Avşar
DDDerya Doğanay
Derya Doğanay
EMESRA MERTOĞLU
ESRA MERTOĞLU
Background: The escalation of multidrug-resistant (MDR) Klebsiella pneumoniae infections poses a severe global health threat, necessitating the exploration of alternative therapeutic strategies such as drug repurposing. This study aims to investigate the intrinsic antibacterial activity of the antidiabetic drug metformin and its adjuvant potential when combined with conventional antibiotics against K. pneumoniae. Materials and Methods: The antimicrobial effects of metformin were evaluated against the reference strain K. pneumoniae ATCC 700603 and an MDR clinical isolate obtained from an intensive care unit. Minimum Inhibitory Concentration (MIC) values were determined using the microdilution method. Interaction studies between metformin and three antibiotics (Levofloxacin, Amikacin, and Ceftazidime) were conducted using the checkerboard assay. The results were interpreted based on the Fractional Inhibitory Concentration Index (FICI). Results: Metformin monotherapy exhibited weak intrinsic antibacterial activity (MIC ≥ 500 µg/mL) against both the reference strain and the clinical isolate. In combination assays, metformin demonstrated an antagonistic effect with Levofloxacin, while its interactions with Amikacin and Ceftazidime were classified as indifferent. The observed antagonism with Levofloxacin is attributed to metformin’s antioxidant properties, which likely mitigate the oxidative stress required for the bactericidal action of fluoroquinolones. Furthermore, the lack of synergy with Amikacin suggests that metformin-induced disruption of the Proton Motive Force (PMF) may hinder the intracellular uptake of aminoglycosides. Conclusion: The findings indicate that metformin is ineffective as a standalone antibacterial agent against K. pneumoniae. Moreover, its adjuvant potential is highly dependent on the antibiotic class and strain-specific resistance mechanisms. Contrary to some reports of synergy, this study highlights the risk of antagonism, particularly with fluoroquinolones. Further standardized mechanistic studies are required to define the specific therapeutic windows for metformin as an antimicrobial adjuvant.

28 October 2025 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
PDF file
DDDerya Doğanay
Derya Doğanay
IAİbRahi̇m Serkan Avşar
İbRahi̇m Serkan Avşar
ŞAŞevval Maral Özcan Aykol
Şevval Maral Özcan Aykol
GÇGamze ÇAMLIK
Gamze ÇAMLIK
BBBesa Bi̇lAkaya
Besa Bi̇lAkaya
İDİsmail Tuncer Değim
İsmail Tuncer Değim
Background/aim: This study evaluates the challenges associated with overcoming antimicrobial resistance and innovative approaches to combat multidrug-resistant (MDR) bacterial infections. Materials and methods: Novel codoped carbon quantum dots (CCQDs) were synthesized using citric acid as the carbon source and L-cysteine as the nitrogen codoping atom. The formulation in which citric acid was retained was designated as CCQDs-1, whereas the purified version, from which citric acid was removed, was termed CCQDs-2. The antibacterial properties of CCQDs-1 and CCQDs-2 were compared using the agar well diffusion method. This study comprehensively characterizes these nanomaterials and evaluates their antibacterial potential, both alone and in combination with antibiotics, against a spectrum of gram-positive (G+) and gram-negative (G‒) bacterial strains. Results: The study demonstrates the significant antibacterial efficacy of CCQDs, with notable variations observed between citric acid-containing and citric acid-neutralized formulations. The QDs exhibited remarkable characteristics, including a quantum yield of 90.3%–90.6%, intense fluorescence, and distinctive interactions with various antibiotics. In addition to their intrinsic antibacterial activity, the QDs also exhibited synergistic effects when combined with certain antibiotics. A synergistic effect was particularly observed when CCQDs-2 were combined with antibiotics such as gentamicin, levofloxacin, and clindamycin, suggesting potential mechanisms such as membrane permeability disruption and efflux pump saturation. Conclusion: These findings underscore the promising potential of carbon-based QDs as innovative, biocompatible solutions to address the critical global challenge of antimicrobial resistance.

31 August 2026 in Journal of New Results in Science
Verified
Journal Article
Open access
DDDerya Doğanay
Derya Doğanay
İAİbrahim Serkan Avşar
İbrahim Serkan Avşar
MAMüzeyyen Aydın
Müzeyyen Aydın
EMESRA MERTOĞLU
ESRA MERTOĞLU
Candida species remain the most prevalent pathogens in nosocomial fungal infections. However, invasive infections caused by non-Candida opportunistic fungi, have emerged as a significant concern, particularly in immunocompromised patients. The widespread use of antifungal agents in intensive care units (ICUs) further accelerates the development of resistant species. This retrospective study aimed to evaluate the species distribution and antifungal susceptibility of fungi isolated from various clinical samples at a university hospital in Istanbul during the Corona virus Disease 19 (COVID-19) pandemic (2020–2022). Isolates were identified using germ tube testing and the VITEK 2 Compact® system. Susceptibility was tested against fluconazole, voriconazole, caspofungin, micafungin, amphotericin B, and flucytosine. A total of 279 isolates were obtained from 243 patients, with 66% (n=185) originating from the ICU. Urine was the most frequent specimen type (48%). Candida species accounted for 94% (n=264) of the isolates, while 6% (n=15) were non-Candida species. The findings revealed that Candida albicans exhibited the highest resistance to voriconazole (12.3%). Notably, 37.5% of Cryptococcus laurentii isolates displayed elevated minimum inhibitory concentration (MIC) values to both caspofungin and micafungin. Furthermore, Trichosporon asahii demonstrated concerningly high MICs in 71.4% of the isolates to fluconazole, caspofungin, and micafungin. Increasing fungal infection frequency, rising Candida resistance, and elevated MIC profiles in rare species pose critical clinical challenges. Continuous monitoring of local susceptibility and MIC patterns is essential to mitigate the high mortality and morbidity associated with fungal pathogens during and after pandemic periods. These results highlight the urgent need for surveillance.

27 November 2025
Verified
Book
Open access
PDF file
İAİbrahim Serkan Avşar
İbrahim Serkan Avşar
HÇHilal Avan Çelebi
Hilal Avan Çelebi
EPEsra Pezik
Esra Pezik
EHElif Ebrar Hisli
Elif Ebrar Hisli
UBUmay Merve Güven Bölgen
Umay Merve Güven Bölgen
EHEylül Haravı
Eylül Haravı